Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Expert Opinion on Pharmacotherapy|February 19, 2013
An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomitingAlessandra Fabi, Paola Malaguti
Critical Reviews in Oncology/Hematology|September 5, 2006
Chemotherapy in neoplastic meningitisAndrea Pace, Alessandra Fabi
Recenti Progressi in Medicina|August 6, 2019
[LHRH analogs: current role in early and advanced breast cancer treatment of premenopausal patients.]Alessandra Fabi, Giovanna Catania
Translational Lung Cancer Research|February 3, 2017
Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastasesAlessandra Fabi, Antonello Vidiri
Clinical Breast Cancer|December 31, 2022
Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact AnalysisSandro Barni, Alessandra Fabi, Fausto Petrelli
Journal of Molecular Medicine (Berlin, Germany)|May 28, 2014
Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinicAlessandra Fabi, Marcella Mottolese, Oreste Segatto
Expert Opinion on Pharmacotherapy|September 23, 2008
HER-2-positive metastatic breast cancer: trastuzumab and beyondGiulio Metro, Marcella Mottolese, Alessandra Fabi
Current Opinion in Oncology|August 14, 2010
Supportive care in neurooncologyAndrea Pace, Giulio Metro, Alessandra Fabi
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2016
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Alessandra Fabi, Paola Malaguti, Sabrina Vari, et al.
Anticancer Research|December 26, 2012
The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directionsPaola Malaguti, Sabrina Vari, Francesco Cognetti, et al.
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Expert Opinion on Pharmacotherapy|February 19, 2013
An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomitingAlessandra Fabi, Paola Malaguti
Critical Reviews in Oncology/Hematology|September 5, 2006
Chemotherapy in neoplastic meningitisAndrea Pace, Alessandra Fabi
Recenti Progressi in Medicina|August 6, 2019
[LHRH analogs: current role in early and advanced breast cancer treatment of premenopausal patients.]Alessandra Fabi, Giovanna Catania
Translational Lung Cancer Research|February 3, 2017
Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastasesAlessandra Fabi, Antonello Vidiri
Clinical Breast Cancer|December 31, 2022
Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact AnalysisSandro Barni, Alessandra Fabi, Fausto Petrelli
Journal of Molecular Medicine (Berlin, Germany)|May 28, 2014
Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinicAlessandra Fabi, Marcella Mottolese, Oreste Segatto
Expert Opinion on Pharmacotherapy|September 23, 2008
HER-2-positive metastatic breast cancer: trastuzumab and beyondGiulio Metro, Marcella Mottolese, Alessandra Fabi
Current Opinion in Oncology|August 14, 2010
Supportive care in neurooncologyAndrea Pace, Giulio Metro, Alessandra Fabi
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2016
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Alessandra Fabi, Paola Malaguti, Sabrina Vari, et al.
Anticancer Research|December 26, 2012
The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directionsPaola Malaguti, Sabrina Vari, Francesco Cognetti, et al.
Pageof 27